Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

NCT05532072 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Graves Ophthalmopathy

Interventions

DRUG: Rapamycin
DRUG: Methylprednisolone

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]